We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
02 Dec 19
ViGeneron will use the funds to advance the development of its next-generation ophthalmic gene therapy pipeline and vector…
27 Nov 19
The new in-vitro HFpEF model is developed based on Novoheart’s 3-D human ventricular cardiac organoid chamber (hvCOC) technology
19 Nov 19
The regulator has approved the biosimilar based on the review of a comprehensive data package, demonstrating biosimilarity of…
15 Nov 19
The new gene therapy innovation centre is planned to be established alongside FDB's existing cGMP gene therapy manufacturing…
12 Nov 19
The transaction is expected to be completed in the first half of 2020, subject to fulfilment of certain…
22 Oct 19
The transaction is expected to be completed in the first quarter of 2020 and is subject to customary…
17 Oct 19
The transaction is expected to close in the first half of 2020, subject to the approval of Achillion…
17 Sep 19
The proposed transaction is expected to strengthen Lundbeck’s operations, accelerate its late-stage pipeline, and provides access to new…
05 Sep 19
Theragnostics’ technology platform enables the development of molecular radiotherapy based on a PARPi for imaging and treating cancer
04 Sep 19
US-based biopharmaceutical company Vertex has signed a definitive agreement to acquire Semma Therapeutics, a USK-based biotechnology company, for…